首页 » 细胞株Cell Lines 72及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 72及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV72
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   NCI-H249

AC   CVCL_A537

SY   H249; H-249; NCIH249

DR   ATCC; CRL-5827

DR   BioSample; SAMN03151645

DR   BioSample; SAMN03151860

DR   BioSample; SAMN03471746

DR   Cosmic; 755460

DR   Cosmic; 877204

DR   Cosmic; 980931

DR   Cosmic; 1006529

DR   Cosmic; 1021857

DR   Cosmic; 1032397

DR   Cosmic; 2125249

DR   GEO; GSM845545

DR   GEO; GSM844646

DR   KCLB; 90249

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20143388;

WW   http://www.atcc.org/support/faqs/4bf60/NCIH249%20ATCC%20CRL5827-1073.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5827; true.

CC   Discontinued: KCLB; 90249; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H250

AC   CVCL_1554

SY   H250; H-250

DR   CLO; CLO_0008078

DR   ATCC; CRL-5828

DR   BioSample; SAMN03471747

DR   ChEMBL-Cells; CHEMBL3308294

DR   ChEMBL-Targets; CHEMBL2366289

DR   Cosmic; 688020

DR   Cosmic; 924241

DR   Cosmic; 1021858

DR   Cosmic-CLP; 924241

DR   GDSC; 924241

DR   GEO; GSM1670235

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=27397505;

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Brain.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 9,13

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2509

AC   CVCL_A538

SY   H2509; H-2509

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2527

AC   CVCL_A539

SY   H2527; H-2527

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2540

AC   CVCL_A540

SY   H2540; H-2540

RX   PubMed=8806092;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2552

AC   CVCL_A541

SY   H2552; H-2552

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2562

AC   CVCL_X977

SY   H2562; H-2562

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2580

AC   CVCL_A542

SY   H2580; H-2580

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2591

AC   CVCL_A543

SY   H2591; H-2591

DR   BioSample; SAMN03471042

DR   Cosmic; 1032379

DR   Cosmic-CLP; 1240131

DR   GDSC; 1240131

DR   GEO; GSM1669821

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,14

ST   D13S317: 12

ST   D16S539: 10,12

ST   D18S51: 12

ST   D21S11: 30,32.2

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 19,22

ST   Penta D: 12

ST   Penta E: 5,10

ST   TH01: 8

ST   TPOX: 8,12

ST   vWA: 16,17

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2594

AC   CVCL_A544

SY   H2594; H-2594

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2595

AC   CVCL_A545

SY   H2595; H-2595

DR   EFO; EFO_0006682

DR   BioSample; SAMN03471011

DR   Cosmic; 1032381

DR   Cosmic; 1087354

DR   Cosmic-CLP; 1240132

DR   GDSC; 1240132

DR   GEO; GSM1669822

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 12,24

ST   D21S11: 29,31.2

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 7,9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 13,14

ST   Penta E: 11,13

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 15,16

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2596

AC   CVCL_A546

SY   H2596; H-2596

DR   EFO; EFO_0006683

DR   BioSample; SAMN03471021

DR   Cosmic; 1032390

DR   Cosmic; 1087355

DR   GDSC; 1240133

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 29,33.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 13,16

ST   FGA: 20

ST   Penta D: 12,13

ST   Penta E: 12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2597

AC   CVCL_A547

SY   H2597; H-2597

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2600

AC   CVCL_A548

SY   H2600; H-2600

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2618

AC   CVCL_A549

SY   H2618; H-2618

DR   Cosmic; 1032391

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2679

AC   CVCL_A550

SY   H2679; H-2679

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2691

AC   CVCL_A551

SY   H2691; H-2691

DR   BioSample; SAMN03471020

DR   Cosmic; 1087356

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 21

ST   D21S11: 30,31

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 10,13

ST   Penta E: 8,9

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2706

AC   CVCL_A552

SY   H2706; H-2706

RX   PubMed=8806092;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2712

AC   CVCL_Y289

SY   H2712; H-2712

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2722

AC   CVCL_U994

SY   H2722; H-2722

DR   EFO; EFO_0006684

DR   BioSample; SAMN03471016

DR   Cosmic; 1995413

DR   Cosmic-CLP; 1290812

DR   GDSC; 1290812

DR   GEO; GSM1669823

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y (Cosmic-CLP)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 10,11

ST   D13S317: 11 (Cosmic-CLP)

ST   D13S317: 7.2,11 (PubMed=25877200)

ST   D16S539: 13

ST   D18S51: 11,13

ST   D21S11: 29,33.2

ST   D3S1358: 17

ST   D5S818: 9,11

ST   D7S820: 10,11

ST   D8S1179: 11,15

ST   FGA: 23

ST   Penta D: 10,13

ST   Penta E: 5,19

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2731

AC   CVCL_U995

SY   H2731; H-2731

DR   BioSample; SAMN03471019

DR   Cosmic-CLP; 1240134

DR   GDSC; 1240134

DR   GEO; GSM1669824

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13 (Cosmic-CLP)

ST   D13S317: 11 (PubMed=25877200)

ST   D16S539: 13

ST   D18S51: 15

ST   D21S11: 30,31.2

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 8,14

ST   D8S1179: 8,12

ST   FGA: 21

ST   Penta D: 11,12

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2795

AC   CVCL_U996

SY   H2795; H-2795

DR   EFO; EFO_0006685

DR   BioSample; SAMN03471022

DR   Cosmic; 1995414

DR   Cosmic-CLP; 1290813

DR   GDSC; 1290813

DR   GEO; GSM1669825

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11,13

ST   D16S539: 11

ST   D18S51: 11,16

ST   D19S433: 15

ST   D21S11: 29,30

ST   D2S1338: 18,25

ST   D3S1358: 14,15

ST   D5S818: 9,11

ST   D7S820: 10,12

ST   D8S1179: 12,13

ST   FGA: 23

ST   Penta D: 9,13

ST   Penta E: 7,13

ST   TH01: 6

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H28

AC   CVCL_1555

SY   H28; H-28; HUT-28; HUT 28; HuT 28; HUT28; Hut28; HuT28

DR   CLO; CLO_0008079

DR   EFO; EFO_0006686

DR   ATCC; CRL-5820

DR   BioSample; SAMN03471010

DR   CCLE; NCIH28_PLEURA

DR   ChEMBL-Cells; CHEMBL3308775

DR   ChEMBL-Targets; CHEMBL1075541

DR   Cosmic; 688059

DR   Cosmic; 733814

DR   Cosmic; 877108

DR   Cosmic; 877350

DR   Cosmic; 886387

DR   Cosmic; 908470

DR   Cosmic; 980995

DR   Cosmic; 1032386

DR   Cosmic; 1146909

DR   Cosmic; 1152495

DR   Cosmic; 1481543

DR   Cosmic; 1522766

DR   Cosmic; 1541208

DR   Cosmic; 1749556

DR   Cosmic; 1963325

DR   Cosmic; 1995572

DR   Cosmic; 2474149

DR   Cosmic-CLP; 908470

DR   GDSC; 908470

DR   GEO; GSM434272

DR   GEO; GSM726267

DR   GEO; GSM794268

DR   GEO; GSM887425

DR   GEO; GSM888504

DR   GEO; GSM1670236

DR   IGRhCellID; H28GEO

DR   KCLB; 90028

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=21642991;

RX   PubMed=22460905;

RX   PubMed=23830731;

RX   PubMed=24926545;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90028; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D18S51: 19

ST   D21S11: 29,30

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,12

ST   FGA: 19.2,21

ST   Penta D: 9,10

ST   Penta E: 10,16

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 14,15

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2803

AC   CVCL_U997

SY   H2803; H-2803

DR   EFO; EFO_0006687

DR   BioSample; SAMN03471013

DR   Cosmic; 1995415

DR   Cosmic-CLP; 1240135

DR   GDSC; 1240135

DR   GEO; GSM1669826

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 21

ST   D21S11: 30,31

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 10,13

ST   Penta E: 8,9

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2804

AC   CVCL_U998

SY   H2804; H-2804

DR   EFO; EFO_0006688

DR   BioSample; SAMN03471014

DR   Cosmic; 1995416

DR   Cosmic-CLP; 1240136

DR   GDSC; 1240136

DR   GEO; GSM1669827

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9,11

ST   D18S51: 18

ST   D21S11: 28,30

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 9

ST   D8S1179: 13,15

ST   FGA: 23

ST   Penta D: 13

ST   Penta E: 7,10

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2810

AC   CVCL_U999

SY   H2810; H-2810

DR   EFO; EFO_0006689

DR   BioSample; SAMN03471017

DR   Cosmic-CLP; 1240137

DR   GDSC; 1240137

DR   GEO; GSM1669828

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 10,11

ST   D18S51: 12

ST   D21S11: 29

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 7,12

ST   D8S1179: 13

ST   FGA: 20,21.2

ST   Penta D: 14

ST   Penta E: 8,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2818

AC   CVCL_V000

SY   H2818; H-2818

DR   Cosmic; 1995417

DR   Cosmic-CLP; 1290814

DR   GDSC; 1290814

DR   GEO; GSM1669829

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H285

AC   CVCL_A553

SY   H285; H-285

DR   ATCC; CRL-5829

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Discontinued: ATCC; CRL-5829; true.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2850

AC   CVCL_Y290

SY   H2850; H-2850

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2869

AC   CVCL_V001

SY   H2869; H-2869

DR   Cosmic; 1995418

DR   Cosmic-CLP; 1240138

DR   GDSC; 1240138

DR   GEO; GSM1669830

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 13

ST   D5S818: 12,13

ST   D7S820: 7,8

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C4282; Biphasic mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2882

AC   CVCL_5158

SY   H2882; H-2882

DR   Cosmic; 755471

DR   Cosmic; 903621

DR   Cosmic; 1146910

DR   GEO; GSM253402

DR   GEO; GSM434255

DR   GEO; GSM794368

DR   IGRhCellID; H2882GEO

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S844 ! NCI-BL2882

SX   Female

CA   Cancer cell line

//

ID   NCI-H2887

AC   CVCL_5159

SY   H2887; H-2887

DR   Cosmic; 903622

DR   Cosmic; 1146911

DR   GEO; GSM253355

DR   GEO; GSM434256

DR   GEO; GSM794369

DR   IGRhCellID; H2887GEO

RX   PubMed=10987304;

RX   PubMed=11314036;

RX   PubMed=12759538;

RX   PubMed=20679594;

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 12

ST   vWA: 17

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S845 ! NCI-BL2887

SX   Male

CA   Cancer cell line

//

ID   NCI-H289

AC   CVCL_A554

SY   H289: H-289

DR   Cosmic; 877205

DR   Cosmic; 1021859

DR   Cosmic; 1320183

DR   GEO; GSM794279

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=20679594;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 17,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E095 ! NCI-BL289

SX   Female

CA   Cancer cell line

//

ID   NCI-H290

AC   CVCL_A555

SY   H290: H-290; HUT-290; Hut-290; HUT 290; HUT290

DR   BioSample; SAMN03471037

DR   Cosmic; 733817

DR   Cosmic; 877270

DR   Cosmic; 877403

DR   Cosmic; 886389

DR   Cosmic; 980996

DR   Cosmic; 1032387

DR   Cosmic; 1152498

DR   Cosmic; 1995419

DR   Cosmic-CLP; 1240139

DR   GDSC; 1240139

DR   GEO; GSM794280

DR   GEO; GSM1669831

DR   KCLB; 90290

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=23830731;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90290; probable.

ST   Source(s): Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 14,15

ST   D19S433: 13,15

ST   D21S11: 28,31.2

ST   D2S1338: 17,19

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 10,14

ST   FGA: 21,22

ST   Penta D: 11,12

ST   Penta E: 7,11

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H292

AC   CVCL_0455

SY   H292; H-292; NCI-HUT-292; Hut292; NCIH292

DR   BTO; BTO:0002418

DR   CLO; CLO_0008080

DR   EFO; EFO_0006690

DR   MCCL; MCC:0000353

DR   CLDB; cl3653

DR   CLDB; cl3654

DR   ATCC; CRL-1848

DR   BCRC; 60372

DR   BCRJ; 0187

DR   BioSample; SAMN03471312

DR   CCLE; NCIH292_LUNG

DR   CCRID; 3111C0001CCC000233

DR   CCRID; 3131C0001000700122

DR   ChEMBL-Cells; CHEMBL3308637

DR   ChEMBL-Targets; CHEMBL614733

DR   Cosmic; 753604

DR   Cosmic; 844598

DR   Cosmic; 877404

DR   Cosmic; 1017828

DR   Cosmic; 1047099

DR   Cosmic; 1152499

DR   Cosmic; 1188584

DR   Cosmic; 1288262

DR   Cosmic; 1466803

DR   Cosmic; 1519249

DR   Cosmic; 1520933

DR   Cosmic; 1520947

DR   Cosmic; 1870272

DR   Cosmic; 1995573

DR   Cosmic-CLP; 753604

DR   ECACC; 91091815

DR   GDSC; 753604

DR   GEO; GSM206489

DR   GEO; GSM784237

DR   GEO; GSM794281

DR   GEO; GSM888505

DR   GEO; GSM1670237

DR   ICLC; HTL96009

DR   KCB; KCB 200822YJ

DR   KCLB; 21848

DR   SKY/M-FISH/CGH; 2844

RX   PubMed=8806092;

RX   PubMed=15193437;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 21848; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 10

ST   D8S1179: 11,14

ST   FGA: 22,26

ST   Penta D: 9

ST   Penta E: 13,15

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C45544; Lung mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2925

AC   CVCL_Y291

SY   H2925; H-2925

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H295

AC   CVCL_0456

SY   H295; H-295; NCI-H-295

DR   BTO; BTO:0002587

DR   CLO; CLO_0008081

DR   MCCL; MCC:0000502

DR   ATCC; CRL-10296

DR   BCRC; 60354

DR   BioSample; SAMN03471298

DR   Cosmic; 684682

DR   Cosmic; 908466

DR   Cosmic; 1179076

DR   Cosmic; 2239455

DR   Cosmic; 2364100

DR   TOKU-E; 2687

DR   Wikidata; Q28226675

RX   PubMed=2386954;

RX   PubMed=8056157;

RX   PubMed=8404594;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=15541570;

RX   PubMed=21924324;

RX   PubMed=22266826;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-402.html

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H295A

AC   CVCL_0457

SY   H295A; H-295A

DR   BTO; BTO:0005669

DR   MCCL; MCC:0000354

RX   PubMed=9024219;

RX   PubMed=15541570;

RX   PubMed=18000308;

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R

AC   CVCL_0458

SY   H295R; H-295R; H295R-S1

DR   BTO; BTO:0002588

DR   CLO; CLO_0008082

DR   EFO; EFO_0002289

DR   MCCL; MCC:0000355

DR   ATCC; CRL-2128

DR   CCRID; 3111C0001CCC000256

DR   ChEMBL-Cells; CHEMBL3307998

DR   ChEMBL-Targets; CHEMBL612593

DR   CLS; 300483/p789_NCI-H295R

DR   Cosmic; 1172633

DR   Cosmic; 1191070

DR   Cosmic; 1622873

DR   Cosmic; 2364101

DR   Cosmic; 2574494

DR   IGRhCellID; NCIH295R

DR   Wikidata; Q25323725

RX   PubMed=15541570;

RX   PubMed=18000308;

RX   PubMed=21924324;

RX   PubMed=22266826;

RX   PubMed=23951072;

WW   https://en.wikipedia.org/wiki/H295R

ST   Source(s): ATCC; CLS

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 17

ST   D21S11: 32.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 13

ST   FGA: 19.2,24

ST   Penta D: 8

ST   Penta E: 5,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R-S2

AC   CVCL_S901

SY   H295R-S2

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R-S3

AC   CVCL_S902

SY   H295R-S3

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H2973

AC   CVCL_E105

SY   H2973; H-2973

RX   PubMed=11030152;

RX   PubMed=12759538;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H298

AC   CVCL_A556

SY   H298; H-298

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H3026

AC   CVCL_Y292

SY   H3026; H-3026

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3030

AC   CVCL_Y293

SY   H3030; H-3030

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3072

AC   CVCL_Y294

SY   H3072; H-3072

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3118

AC   CVCL_A464

SY   H3118; H-3118

DR   Cosmic; 1288269

DR   Cosmic; 1519250

DR   Cosmic-CLP; 1240140

DR   GDSC; 1240140

DR   GEO; GSM1669832

DR   SKY/M-FISH/CGH; 2845

RX   PubMed=11030152;

RX   PubMed=15193437;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12,14

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,12

ST   vWA: 17

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H3122

AC   CVCL_5160

SY   H3122; H-3122; NCIH3122

DR   Cosmic; 755472

DR   Cosmic; 914951

DR   Cosmic; 1146912

DR   Cosmic; 2245571

DR   Cosmic-CLP; 1240190

DR   GDSC; 1240190

DR   GEO; GSM253349

DR   GEO; GSM434307

DR   GEO; GSM794370

DR   GEO; GSM1374739

DR   GEO; GSM1374740

DR   GEO; GSM1670238

DR   IGRhCellID; H3122GEO

DR   PRIDE; PXD002556

RX   PubMed=11030152;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=24675041;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=20679594;

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 7,9.3

ST   TPOX: 10

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3123

AC   CVCL_Y295

SY   H3123; H-3123

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3166

AC   CVCL_X979

SY   H3166; H-3166

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3211

AC   CVCL_X978

SY   H3211; H-3211

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H322

AC   CVCL_1556

SY   H322; H-322; H322T; NCI-H322T; NCI-322

DR   BTO; BTO:0003007

DR   CLO; CLO_0008083

DR   EFO; EFO_0006691

DR   CLDB; cl3655

DR   ATCC; CRL-5806

DR   BioSample; SAMN03471699

DR   BioSample; SAMN03471740

DR   BioSample; SAMN03473287

DR   CCLE; NCIH322_LUNG

DR   ChEMBL-Cells; CHEMBL3307405

DR   ChEMBL-Targets; CHEMBL614573

DR   Cosmic; 687822

DR   Cosmic; 801589

DR   Cosmic; 844830

DR   Cosmic; 876143

DR   Cosmic; 903571

DR   Cosmic; 917976

DR   Cosmic; 929972

DR   Cosmic; 932922

DR   Cosmic; 934547

DR   Cosmic; 980962

DR   Cosmic; 1028935

DR   Cosmic; 1032434

DR   Cosmic; 1146913

DR   Cosmic; 1152500

DR   Cosmic; 1239903

DR   Cosmic; 1802317

DR   Cosmic; 1870261

DR   Cosmic; 1891884

DR   Cosmic; 2042867

DR   Cosmic; 2125250

DR   ECACC; 95111734

DR   GEO; GSM206490

DR   GEO; GSM253358

DR   GEO; GSM434333

DR   GEO; GSM784245

DR   GEO; GSM794282

DR   GEO; GSM827434

DR   GEO; GSM887426

DR   GEO; GSM888506

DR   GEO; GSM1374741

DR   IGRhCellID; NCIH322

DR   KCLB; 90322

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.

CC   Discontinued: ATCC; CRL-5806; true.

CC   Discontinued: KCLB; 90322; probable.

ST   Source(s): ATCC; ECACC; PubMed=11416159; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; ECACC; PubMed=11416159; PubMed=20679594)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 17

ST   D21S11: 28

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 7

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H322M

AC   CVCL_1557

SY   NCI.H322M; H322M; H-322M

DR   BTO; BTO:0004182

DR   ChEMBL-Cells; CHEMBL3307710

DR   ChEMBL-Targets; CHEMBL614803

DR   Cosmic; 875851

DR   Cosmic; 905967

DR   Cosmic; 974293

DR   Cosmic; 1092620

DR   Cosmic; 1175865

DR   Cosmic; 1305348

DR   Cosmic; 1312333

DR   Cosmic; 1995574

DR   Cosmic; 1998462

DR   Cosmic-CLP; 905967

DR   GDSC; 905967

DR   GEO; GSM50215

DR   GEO; GSM50278

DR   GEO; GSM434296

DR   GEO; GSM750802

DR   GEO; GSM799342

DR   GEO; GSM799405

DR   GEO; GSM1153413

DR   GEO; GSM1181269

DR   GEO; GSM1181316

DR   GEO; GSM1374742

DR   GEO; GSM1670239

DR   IGRhCellID; H322M_03GEO

DR   SKY/M-FISH/CGH; 2797

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=11

WW   http://tcpaportal.org/mclp/

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 35.3 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 28

ST   D2S1338: 19,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 22

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1556 ! NCI-H322

SX   Male

CA   Cancer cell line

//

ID   NCI-H324

AC   CVCL_3953

SY   H324; H-324

DR   BTO; BTO:0003005

DR   Cosmic; 844594

DR   Cosmic; 877238

DR   Cosmic; 877406

DR   Cosmic; 903572

DR   Cosmic; 1152501

DR   Cosmic; 1891885

DR   GEO; GSM794283

RX   PubMed=8806092;

RX   PubMed=20679594;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H3255

AC   CVCL_6831

SY   H3255; H-3255; H3255_DA

DR   EFO; EFO_0003123

DR   ATCC; CRL-2882

DR   BioSample; SAMN03471808

DR   CCLE; NCIH3255_LUNG

DR   Cosmic; 897734

DR   Cosmic; 903623

DR   Cosmic; 914952

DR   Cosmic; 1028937

DR   Cosmic; 1128245

DR   Cosmic; 1146914

DR   Cosmic-CLP; 1247873

DR   GDSC; 1247873

DR   GEO; GSM63349

DR   GEO; GSM253411

DR   GEO; GSM434297

DR   GEO; GSM794371

DR   GEO; GSM827356

DR   GEO; GSM1374743

DR   GEO; GSM1669833

DR   IGRhCellID; H3255_DAGEO

DR   PRIDE; PXD002224

DR   PRIDE; PXD002556

RX   PubMed=11030152;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=26202522;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep membrane proteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2882; true.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594;

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 11,13

ST   D16S539: 8

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H3255DR

AC   CVCL_DI56

SY   H3255DR

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DI55 ! NCI-H3255GR

SX   Female

CA   Cancer cell line

//

ID   NCI-H3255GR

AC   CVCL_DI55

SY   H3255GR; H3255 GR

DR   Cosmic; 1128246

RX   PubMed=16906227;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6831 ! NCI-H3255

SX   Female

CA   Cancer cell line

//

ID   NCI-H3282

AC   CVCL_X980

SY   H3282; H-3282

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H345

AC   CVCL_1558

SY   H345; H-345; NCI H345; NCIH345

DR   BTO; BTO:0003019

DR   CLO; CLO_0008084

DR   EFO; EFO_0006692

DR   ATCC; HTB-180

DR   BioSample; SAMN03471018

DR   BioSample; SAMN03472734

DR   ChEMBL-Cells; CHEMBL3307324

DR   ChEMBL-Targets; CHEMBL614195

DR   Cosmic; 688021

DR   Cosmic; 755464

DR   Cosmic; 844551

DR   Cosmic; 850440

DR   Cosmic; 877206

DR   Cosmic; 877355

DR   Cosmic; 1006525

DR   Cosmic; 1021860

DR   Cosmic; 1152465

DR   Cosmic; 1219101

DR   Cosmic; 1239938

DR   Cosmic; 2125251

DR   Cosmic-CLP; 688021

DR   GDSC; 688021

DR   GEO; GSM169441

DR   GEO; GSM380512

DR   GEO; GSM784200

DR   GEO; GSM794284

DR   GEO; GSM844647

DR   GEO; GSM1670240

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 8

ST   D18S51: 12,13

ST   D21S11: 29,31

ST   D3S1358: 18

ST   D5S818: 11,12 (ATCC; Cosmic-CLP)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 9,13

ST   D8S1179: 14,16

ST   FGA: 20

ST   Penta D: 12,13

ST   Penta E: 14

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H358

AC   CVCL_1559

SY   H358; H-358; NCIH358

DR   BTO; BTO:0002835

DR   CLO; CLO_0008085

DR   EFO; EFO_0002291

DR   CLDB; cl3656

DR   ATCC; CRL-5807

DR   BioSample; SAMN03471313

DR   CCLE; NCIH358_LUNG

DR   CCRID; 3131C0001000700151

DR   ChEMBL-Cells; CHEMBL3307543

DR   ChEMBL-Targets; CHEMBL614135

DR   Cosmic; 722039

DR   Cosmic; 724875

DR   Cosmic; 877106

DR   Cosmic; 903573

DR   Cosmic; 908465

DR   Cosmic; 910563

DR   Cosmic; 914944

DR   Cosmic; 929970

DR   Cosmic; 934545

DR   Cosmic; 980963

DR   Cosmic; 1004699

DR   Cosmic; 1028934

DR   Cosmic; 1032435

DR   Cosmic; 1052333

DR   Cosmic; 1146915

DR   Cosmic; 1219075

DR   Cosmic; 1239902

DR   Cosmic; 1600603

DR   Cosmic; 1741780

DR   Cosmic; 1802307

DR   Cosmic; 1870273

DR   Cosmic; 1995575

DR   Cosmic; 2042868

DR   Cosmic-CLP; 908465

DR   ECACC; 95111733

DR   GDSC; 908465

DR   GEO; GSM206491

DR   GEO; GSM253398

DR   GEO; GSM385520

DR   GEO; GSM385531

DR   GEO; GSM434257

DR   GEO; GSM513937

DR   GEO; GSM514321

DR   GEO; GSM784251

DR   GEO; GSM794285

DR   GEO; GSM827468

DR   GEO; GSM844648

DR   GEO; GSM887427

DR   GEO; GSM888507

DR   GEO; GSM1374744

DR   GEO; GSM1670241

DR   IGRhCellID; NCIH358

DR   KCLB; 25807

DR   KCLB; 90358

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=8806101;

RX   PubMed=9649128;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 38 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 12,13

ST   D18S51: 14

ST   D21S11: 28,30

ST   D3S1358: 14,18

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 20,21

ST   Penta D: 10,13

ST   Penta E: 18

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H360

AC   CVCL_A557

SY   H360; H-360

DR   Cosmic; 1152466

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H369

AC   CVCL_A558

SY   H369; H-369

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H372

AC   CVCL_A559

SY   H372; H-372

DR   Cosmic; 844552

DR   Cosmic; 1152467

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H378

AC   CVCL_1560

SY   H378; H-378; NCIH378

DR   CLO; CLO_0008086

DR   ATCC; CRL-5808

DR   BioSample; SAMN03471741

DR   ChEMBL-Cells; CHEMBL3308295

DR   ChEMBL-Targets; CHEMBL2366088

DR   Cosmic; 688022

DR   Cosmic; 850428

DR   Cosmic; 877207

DR   Cosmic; 877356

DR   Cosmic; 980932

DR   Cosmic; 1021861

DR   Cosmic; 1032398

DR   Cosmic; 1152468

DR   Cosmic; 1995576

DR   Cosmic-CLP; 688022

DR   GDSC; 688022

DR   GEO; GSM794286

DR   GEO; GSM845546

DR   GEO; GSM844649

DR   GEO; GSM1670242

DR   IGRhCellID; NCIH378

DR   KCLB; 90378

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A560 ! NCI-H379

SX   Female

CA   Cancer cell line

//

ID   NCI-H379

AC   CVCL_A560

SY   H379; H-379

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1560 ! NCI-H378

SX   Female

CA   Cancer cell line

//

ID   NCI-H432

AC   CVCL_A563

SY   H432; H-432

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A564 ! NCI-H433

SX   Male

CA   Cancer cell line

//

ID   NCI-H433

AC   CVCL_A564

SY   H433; H-433

DR   Cosmic; 1152469

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A563 ! NCI-H432

SX   Male

CA   Cancer cell line

//

ID   NCI-H441

AC   CVCL_1561

SY   H441; H-441; NCI-H441-4; NCI-441; NCIH441

DR   BTO; BTO:0001910

DR   CLO; CLO_0008087

DR   EFO; EFO_0002292

DR   ATCC; HTB-174

DR   ATCC; CRM-HTB-174

DR   BCRC; 60455

DR   BCRJ; 0359

DR   BioSample; SAMN03473121

DR   CCLE; NCIH441_LUNG

DR   ChEMBL-Cells; CHEMBL3308121

DR   ChEMBL-Targets; CHEMBL1075542

DR   Cosmic; 687824

DR   Cosmic; 722048

DR   Cosmic; 801590

DR   Cosmic; 844831

DR   Cosmic; 876144

DR   Cosmic; 897730

DR   Cosmic; 903574

DR   Cosmic; 908460

DR   Cosmic; 914949

DR   Cosmic; 917992

DR   Cosmic; 1006533

DR   Cosmic; 1028948

DR   Cosmic; 1052332

DR   Cosmic; 1146916

DR   Cosmic; 1219076

DR   Cosmic; 1239882

DR   Cosmic; 1802306

DR   Cosmic; 1870274

DR   Cosmic; 1945871

DR   Cosmic; 1995577

DR   Cosmic; 2042863

DR   Cosmic; 2125252

DR   Cosmic-CLP; 908460

DR   GDSC; 908460

DR   GEO; GSM206492

DR   GEO; GSM253415

DR   GEO; GSM353231

DR   GEO; GSM385521

DR   GEO; GSM385532

DR   GEO; GSM434308

DR   GEO; GSM784265

DR   GEO; GSM794287

DR   GEO; GSM827516

DR   GEO; GSM844650

DR   GEO; GSM887428

DR   GEO; GSM888508

DR   GEO; GSM1670243

DR   IGRhCellID; NCIH441

DR   IZSLER; BS TCL 215

DR   PRIDE; PXD002556

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-294.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).

CC   Doubling time: 80 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 9,13

ST   D18S51: 18,19

ST   D21S11: 32.2

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 8,14

ST   FGA: 24,25

ST   Penta D: 10,12

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C5650; Papillary lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H441/CMV-Luc

AC   CVCL_M254

DR   JCRB; JCRB1497

DR   JCRB; NIHS0728

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0728; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 9,13

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17,18

DI   NCIt; C5650; Papillary lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1561 ! NCI-H441

SX   Male

CA   Cancer cell line

//

ID   NCI-H446

AC   CVCL_1562

SY   H446; H-446; NCI-446; NCIH446

DR   CLO; CLO_0008088

DR   EFO; EFO_0002293

DR   ATCC; HTB-171

DR   BioSample; SAMN03473283

DR   CCLE; NCIH446_LUNG

DR   CCRID; 3111C0001CCC000082

DR   CCRID; 3131C0001000700038

DR   ChEMBL-Cells; CHEMBL3307760

DR   ChEMBL-Targets; CHEMBL612440

DR   Cosmic; 688023

DR   Cosmic; 755465

DR   Cosmic; 801352

DR   Cosmic; 844554

DR   Cosmic; 877357

DR   Cosmic; 897516

DR   Cosmic; 929976

DR   Cosmic; 932947

DR   Cosmic; 1006526

DR   Cosmic; 1021863

DR   Cosmic; 1152471

DR   Cosmic; 1219102

DR   Cosmic; 1239939

DR   Cosmic; 1434963

DR   Cosmic; 1995578

DR   Cosmic; 2125198

DR   Cosmic-CLP; 688023

DR   GDSC; 688023

DR   GEO; GSM169448

DR   GEO; GSM380477

DR   GEO; GSM784254

DR   GEO; GSM845547

DR   GEO; GSM887429

DR   GEO; GSM888509

DR   GEO; GSM1670244

DR   GEO; GSM1682798

DR   IGRhCellID; NCIH446

DR   KCB; KCB 200688YJ

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 8

ST   D16S539: 12

ST   D18S51: 12,13

ST   D21S11: 28

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 22

ST   Penta D: 12,13

ST   Penta E: 9,10

ST   TH01: 8,9.3

ST   TPOX: 9,11

ST   vWA: 18,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H449

AC   CVCL_A565

SY   H449; H-449

DR   Cosmic; 1021864

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A566 ! NCI-H450

SX   Female

CA   Cancer cell line

//

ID   NCI-H450

AC   CVCL_A566

SY   H450; H-450

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A565 ! NCI-H449

SX   Female

CA   Cancer cell line

//

ID   NCI-H460

AC   CVCL_0459

SY   NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460

DR   BTO; BTO:0002207

DR   CLO; CLO_0003601

DR   CLO; CLO_0008089

DR   EFO; EFO_0003044

DR   MCCL; MCC:0000356

DR   CLDB; cl1548

DR   ATCC; HTB-177

DR   BCRC; 60373

DR   BioSample; SAMN03471184

DR   CCLE; NCIH460_LUNG

DR   CCLV; CCLV-RIE 0962

DR   CCRID; 3111C0001CCC000355

DR   CCRID; 3131C0001000700039

DR   CGH-DB; 199-1

DR   CGH-DB; 9186-4

DR   ChEMBL-Cells; CHEMBL3307677

DR   ChEMBL-Targets; CHEMBL396

DR   Cosmic; 722064

DR   Cosmic; 724876

DR   Cosmic; 755469

DR   Cosmic; 844595

DR   Cosmic; 875852

DR   Cosmic; 877263

DR   Cosmic; 877407

DR   Cosmic; 897508

DR   Cosmic; 905943

DR   Cosmic; 911996

DR   Cosmic; 931371

DR   Cosmic; 947356

DR   Cosmic; 980964

DR   Cosmic; 1006534

DR   Cosmic; 1017826

DR   Cosmic; 1028956

DR   Cosmic; 1032436

DR   Cosmic; 1044245

DR   Cosmic; 1047102

DR   Cosmic; 1089231

DR   Cosmic; 1092621

DR   Cosmic; 1146917

DR   Cosmic; 1154605

DR   Cosmic; 1152502

DR   Cosmic; 1188592

DR   Cosmic; 1219077

DR   Cosmic; 1239922

DR   Cosmic; 1305349

DR   Cosmic; 1312334

DR   Cosmic; 1434967

DR   Cosmic; 1436013

DR   Cosmic; 1477420

DR   Cosmic; 1802310

DR   Cosmic; 1870275

DR   Cosmic; 1945869

DR   Cosmic; 1995579

DR   Cosmic; 1998463

DR   Cosmic; 2042872

DR   Cosmic; 2125199

DR   Cosmic; 2433756

DR   Cosmic-CLP; 905943

DR   DSMZ; ACC-737

DR   ENCODE; ENCBS398KLJ

DR   ENCODE; ENCBS446PPO

DR   ENCODE; ENCBS460OUE

DR   ENCODE; ENCBS514AAA

DR   ENCODE; ENCBS515AAA

DR   ENCODE; ENCBS641PGO

DR   ENCODE; ENCBS686KKP

DR   ENCODE; ENCBS798ZFS

DR   ENCODE; ENCBS814QPR

DR   GDSC; 905943

DR   GEO; GSM50216

DR   GEO; GSM50279

DR   GEO; GSM206493

DR   GEO; GSM253335

DR   GEO; GSM385522

DR   GEO; GSM385533

DR   GEO; GSM434334

DR   GEO; GSM513936

DR   GEO; GSM514322

DR   GEO; GSM750809

DR   GEO; GSM784193

DR   GEO; GSM794288

DR   GEO; GSM799343

DR   GEO; GSM799406

DR   GEO; GSM827469

DR   GEO; GSM844652

DR   GEO; GSM844651

DR   GEO; GSM847076

DR   GEO; GSM887430

DR   GEO; GSM888510

DR   GEO; GSM1153414

DR   GEO; GSM1181352

DR   GEO; GSM1181361

DR   GEO; GSM1374746

DR   GEO; GSM1374747

DR   GEO; GSM1374748

DR   GEO; GSM1557134

DR   IGRhCellID; NCI-H460%20GEO

DR   IZSLER; BS TCL 197

DR   KCB; KCB 2010102YJ

DR   KCLB; 30177

DR   SKY/M-FISH/CGH; 2798

RX   PubMed=1563005;

RX   PubMed=2041050;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=15746151;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=19941903;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23381221;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24135919;

RX   PubMed=25120651;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=12

WW   http://www.addexbio.com/productdetail?pid=39

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-613.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 17.8 hours (DTP); ~23 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9

ST   D18S51: 13,15

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 17,25

ST   D3S1358: 15,18

ST   D5S818: 9,10

ST   D7S820: 9,12

ST   D8S1179: 12

ST   FGA: 21,23

ST   Penta D: 11,13

ST   Penta E: 5

ST   TH01: 9.3

ST   TPOX: 8 (ATCC; Cosmic-CLP; DSMZ; PubMed=19372543; PubMed=25877200)

ST   TPOX: 9.3 (KCLB)

ST   vWA: 17

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-Luc

AC   CVCL_J264

DR   JCRB; JCRB1407

DR   JCRB; NIHS0658

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0658; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9

ST   D5S818: 9,10

ST   D7S820: 9,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-luc2

AC   CVCL_5J23

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 124316.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-Red-Fluc

AC   CVCL_5J07

SY   NCI-H460 Red-Fluc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW124316

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460M

AC   CVCL_3969

SY   H460M; H-460M; H460-M

DR   BTO; BTO:0002836

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H462

AC   CVCL_A567

SY   H462; H-462

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A568 ! NCI-H463

SX   Male

CA   Cancer cell line

//

ID   NCI-H463

AC   CVCL_A568

SY   H463; H-463

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A567 ! NCI-H462

SX   Male

CA   Cancer cell line

//

ID   NCI-H478

AC   CVCL_A569

SY   H478; H-478

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H498

AC   CVCL_1563

SY   H498; H-498

DR   CLO; CLO_0008090

DR   ATCC; CCL-254

DR   BioSample; SAMN03471385

DR   GEO; GSM513915

DR   GEO; GSM514302

DR   GEO; GSM1448214

DR   KCLB; 10254

RX   PubMed=3479249;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=25926053;

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Peritoneum.

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 8,11

ST   FGA: 22,24

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H508

AC   CVCL_1564

SY   NCI H508; NCIH508; H508; H-508

DR   CLO; CLO_0008091

DR   EFO; EFO_0002294

DR   ATCC; CCL-253

DR   BioSample; SAMN03471384

DR   CCLE; NCIH508_LARGE_INTESTINE

DR   Cosmic; 685870

DR   Cosmic; 908442

DR   Cosmic; 1479606

DR   Cosmic; 1565529

DR   Cosmic; 1708418

DR   Cosmic-CLP; 908442

DR   GDSC; 908442

DR   GEO; GSM513916

DR   GEO; GSM514303

DR   GEO; GSM741253

DR   GEO; GSM887431

DR   GEO; GSM888511

DR   GEO; GSM1448142

DR   GEO; GSM1670245

DR   IZSLER; BS TCL 214

DR   KCLB; 10253

DR   SKY/M-FISH/CGH; 5012

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 32 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Abdominal wall.

ST   Source(s): ATCC; Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 12

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 8,12

ST   FGA: 24,25

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H510A

AC   CVCL_1565

AS   CVCL_3973

SY   H510A; H-510A; NCI-H510; NCIH510; H510; H-510

DR   BTO; BTO:0003023

DR   CLO; CLO_0008092

DR   EFO; EFO_0006693

DR   ATCC; HTB-184

DR   BioSample; SAMN03473048

DR   CCLE; NCIH510_LUNG

DR   ChEMBL-Cells; CHEMBL3308322

DR   ChEMBL-Targets; CHEMBL2366332

DR   Cosmic; 753605

DR   Cosmic; 755466

DR   Cosmic; 897519

DR   Cosmic; 903575

DR   Cosmic; 1006527

DR   Cosmic; 1021865

DR   Cosmic; 1219103

DR   Cosmic; 1995580

DR   Cosmic; 2125210

DR   Cosmic-CLP; 753605

DR   DSMZ; ACC-568

DR   ECACC; 96020944

DR   GDSC; 753605

DR   GEO; GSM169437

DR   GEO; GSM784199

DR   GEO; GSM794289

DR   GEO; GSM887432

DR   GEO; GSM888512

DR   GEO; GSM1670246

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~1 week (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Adrenal gland.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 15,17

ST   D21S11: 30

ST   D3S1358: 16,18

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   D8S1179: 15

ST   FGA: 22

ST   Penta D: 9,11

ST   Penta E: 12,16

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H513

AC   CVCL_A570

SY   H513; H-513; HUT513

DR   ATCC; CRL-5830

DR   BioSample; SAMN03151854

DR   Cosmic; 877271

DR   Cosmic; 877408

DR   Cosmic; 980997

DR   Cosmic; 1032388

DR   Cosmic; 1152503

DR   Cosmic; 1995420

DR   Cosmic-CLP; 1240141

DR   GDSC; 1240141

DR   GEO; GSM1669835

DR   KCLB; 90513

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-H125 derivative.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: ATCC; CRL-5830; true.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 7

ST   D13S317: 11

ST   D16S539: 5,12

ST   D5S818: 10

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3968 ! NCI-H125

SX   Male

CA   Cancer cell line

//

ID   NCI-H520

AC   CVCL_1566

SY   H520; H-520; NCI-HUT-520; NCIH520

DR   BTO; BTO:0003014

DR   CLO; CLO_0008093

DR   EFO; EFO_0003124

DR   ATCC; HTB-182

DR   BCRC; 60124

DR   BioSample; SAMN03471318

DR   BioSample; SAMN03472735

DR   CCLE; NCIH520_LUNG

DR   CCRID; 3111C0001CCC000197

DR   ChEMBL-Cells; CHEMBL3307864

DR   ChEMBL-Targets; CHEMBL614099

DR   Cosmic; 687826

DR   Cosmic; 801591

DR   Cosmic; 876172

DR   Cosmic; 908443

DR   Cosmic; 917988

DR   Cosmic; 929974

DR   Cosmic; 932932

DR   Cosmic; 933580

DR   Cosmic; 945226

DR   Cosmic; 1028955

DR   Cosmic; 1146918

DR   Cosmic; 1219078

DR   Cosmic; 1239911

DR   Cosmic; 1741782

DR   Cosmic; 1802297

DR   Cosmic; 1995581

DR   Cosmic; 2060526

DR   Cosmic; 2125253

DR   Cosmic-CLP; 908443

DR   GDSC; 908443

DR   GEO; GSM63353

DR   GEO; GSM206494

DR   GEO; GSM276781

DR   GEO; GSM276782

DR   GEO; GSM434281

DR   GEO; GSM784258

DR   GEO; GSM794290

DR   GEO; GSM844653

DR   GEO; GSM844654

DR   GEO; GSM887433

DR   GEO; GSM888513

DR   GEO; GSM1374750

DR   GEO; GSM1670247

DR   IGRhCellID; NCIH520

DR   KCB; KCB 2013023YJ

RX   PubMed=8806092;

RX   PubMed=9649128;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,11

ST   D16S539: 8,13

ST   D18S51: 17

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12,13 (ATCC; Cosmic-CLP)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 8,12

ST   D8S1179: 14,16,17

ST   FGA: 22

ST   Penta D: 13

ST   Penta E: 5,14

ST   TH01: 10

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H522

AC   CVCL_1567

SY   NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522

DR   BTO; BTO:0003536

DR   CLO; CLO_0008094

DR   EFO; EFO_0002295

DR   ATCC; CRL-5810

DR   BioSample; SAMN03471314

DR   CCLE; NCIH522_LUNG

DR   ChEMBL-Cells; CHEMBL3308392

DR   ChEMBL-Targets; CHEMBL614387

DR   Cosmic; 875853

DR   Cosmic; 877409

DR   Cosmic; 897509

DR   Cosmic; 903576

DR   Cosmic; 905944

DR   Cosmic; 974294

DR   Cosmic; 980965

DR   Cosmic; 1004696

DR   Cosmic; 1032437

DR   Cosmic; 1044246

DR   Cosmic; 1092622

DR   Cosmic; 1146919

DR   Cosmic; 1154592

DR   Cosmic; 1175866

DR   Cosmic; 1188591

DR   Cosmic; 1219062

DR   Cosmic; 1239883

DR   Cosmic; 1305350

DR   Cosmic; 1312335

DR   Cosmic; 1436012

DR   Cosmic; 1802320

DR   Cosmic; 1870276

DR   Cosmic; 1891886

DR   Cosmic; 1995582

DR   Cosmic; 1998464

DR   Cosmic; 2125185

DR   Cosmic-CLP; 905944

DR   GDSC; 905944

DR   GEO; GSM50217

DR   GEO; GSM50280

DR   GEO; GSM206495

DR   GEO; GSM353230

DR   GEO; GSM434309

DR   GEO; GSM513965

DR   GEO; GSM514350

DR   GEO; GSM750798

DR   GEO; GSM784233

DR   GEO; GSM794291

DR   GEO; GSM799344

DR   GEO; GSM799407

DR   GEO; GSM827479

DR   GEO; GSM847077

DR   GEO; GSM887434

DR   GEO; GSM888514

DR   GEO; GSM1153415

DR   GEO; GSM1181345

DR   GEO; GSM1181346

DR   GEO; GSM1374751

DR   GEO; GSM1374752

DR   GEO; GSM1374753

DR   GEO; GSM1670248

DR   IGRhCellID; NCIH522

DR   KCLB; 25810

DR   KCLB; 90522

DR   SKY/M-FISH/CGH; 2803

RX   PubMed=1563005;

RX   PubMed=2041050;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=7

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 38.2 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 25810; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12 (Cosmic-CLP; PubMed=19372543)

ST   CSF1PO: 10 (ATCC; PubMed=25877200)

ST   D13S317: 10

ST   D16S539: 12

ST   D18S51: 14,18

ST   D19S433: 16

ST   D21S11: 28,31.2

ST   D2S1338: 17,20

ST   D3S1358: 16

ST   D5S818: 10,11 (PubMed=19372543)

ST   D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D7S820: 9,10

ST   D8S1179: 12,13

ST   FGA: 24

ST   Penta D: 11

ST   Penta E: 11

ST   TH01: 7,9.3

ST   TPOX: 9,10

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H524

AC   CVCL_1568

SY   H524; H-524; NCIH524

DR   BTO; BTO:0004825

DR   CLO; CLO_0008095

DR   EFO; EFO_0002296

DR   ATCC; CRL-5831

DR   BioSample; SAMN03472976

DR   CCLE; NCIH524_LUNG

DR   CCRID; 3111C0001CCC000356

DR   ChEMBL-Cells; CHEMBL3308296

DR   ChEMBL-Targets; CHEMBL2366342

DR   Cosmic; 688024

DR   Cosmic; 844555

DR   Cosmic; 850442

DR   Cosmic; 877208

DR   Cosmic; 877358

DR   Cosmic; 908483

DR   Cosmic; 980933

DR   Cosmic; 1032399

DR   Cosmic; 1152472

DR   Cosmic; 1759289

DR   Cosmic; 1891904

DR   Cosmic; 2125200

DR   Cosmic-CLP; 908483

DR   GDSC; 908483

DR   GEO; GSM169442

DR   GEO; GSM794292

DR   GEO; GSM845548

DR   GEO; GSM887435

DR   GEO; GSM888515

DR   GEO; GSM1670249

DR   IGRhCellID; NCIH524

DR   KCB; KCB 2010137YJ

DR   KCLB; 90524

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 100 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90524; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 12,13

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 13,15

ST   FGA: 25

ST   Penta D: 12,13

ST   Penta E: 5,15

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 14,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H526

AC   CVCL_1569

SY   H526; H-526; NCIH526

DR   BTO; BTO:0005366

DR   CLO; CLO_0008096

DR   ATCC; CRL-5811

DR   BioSample; SAMN03473065

DR   CCLE; NCIH526_LUNG

DR   ChEMBL-Cells; CHEMBL3308881

DR   ChEMBL-Targets; CHEMBL2366102

DR   Cosmic; 688025

DR   Cosmic; 755467

DR   Cosmic; 801615

DR   Cosmic; 844556

DR   Cosmic; 844820

DR   Cosmic; 850439

DR   Cosmic; 876164

DR   Cosmic; 877209

DR   Cosmic; 877359

DR   Cosmic; 918012

DR   Cosmic; 929975

DR   Cosmic; 1021866

DR   Cosmic; 1152473

DR   Cosmic; 1219104

DR   Cosmic; 1239940

DR   Cosmic; 1891905

DR   Cosmic; 1995583

DR   Cosmic; 1998284

DR   Cosmic; 2125214

DR   Cosmic-CLP; 688025

DR   GDSC; 688025

DR   GEO; GSM169439

DR   GEO; GSM380478

DR   GEO; GSM380515

DR   GEO; GSM536330

DR   GEO; GSM784231

DR   GEO; GSM794293

DR   GEO; GSM845549

DR   GEO; GSM844655

DR   GEO; GSM887436

DR   GEO; GSM888516

DR   GEO; GSM1374754

DR   GEO; GSM1670250

DR   IGRhCellID; NCIH526

DR   KCLB; 90526

DR   TOKU-E; 2701

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 9

ST   D18S51: 12,15

ST   D21S11: 27,32.2

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 9,12

ST   D8S1179: 14

ST   FGA: 22

ST   Penta D: 13,14

ST   Penta E: 5,13

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H548

AC   CVCL_1570

SY   NCI H548; H548; H-548; NCIH548

DR   CLO; CLO_0008097

DR   ATCC; CCL-249

DR   BioSample; SAMN03471379

DR   GEO; GSM1374755

DR   KCLB; 10249

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=20606684;

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CCL-249; true.

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   FGA: 21,22

ST   TH01: 7

ST   TPOX: 10,11

ST   vWA: 15,18,19 (ATCC)

ST   vWA: 15,18 (KCLB)

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H568

AC   CVCL_A571

SY   H568; H-568

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H571

AC   CVCL_A572

SY   H571; H-571

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H578

AC   CVCL_A573

SY   H578; H-578

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H580

AC   CVCL_A574

SY   H580; H-580

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H596

AC   CVCL_1571

SY   H596; H-596; NCI-HUT-596; NCIH596

DR   BTO; BTO:0002209

DR   CLO; CLO_0008098

DR   EFO; EFO_0006694

DR   ATCC; HTB-178

DR   BioSample; SAMN03472805

DR   CCLE; NCIH596_LUNG

DR   CCRID; 3111C0001CCC000257

DR   ChEMBL-Cells; CHEMBL3307791

DR   ChEMBL-Targets; CHEMBL612256

DR   Cosmic; 687828

DR   Cosmic; 801586

DR   Cosmic; 844832

DR   Cosmic; 876226

DR   Cosmic; 897514

DR   Cosmic; 908459

DR   Cosmic; 918001

DR   Cosmic; 929973

DR   Cosmic; 934548

DR   Cosmic; 1067762

DR   Cosmic; 1146920

DR   Cosmic; 1188588

DR   Cosmic; 1219079

DR   Cosmic; 1239917

DR   Cosmic; 1694668

DR   Cosmic; 1802293

DR   Cosmic; 1995584

DR   Cosmic; 2125254

DR   Cosmic-CLP; 908459

DR   GDSC; 908459

DR   GEO; GSM206496

DR   GEO; GSM434310

DR   GEO; GSM784243

DR   GEO; GSM794294

DR   GEO; GSM844656

DR   GEO; GSM887437

DR   GEO; GSM888517

DR   GEO; GSM1374756

DR   GEO; GSM1374757

DR   GEO; GSM1670251

DR   IGRhCellID; NCIH596

DR   KCLB; 90596

DR   PRIDE; PXD002556

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=8806101;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 18

ST   D21S11: 29

ST   D3S1358: 14

ST   D5S818: 11,13

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 23,25

ST   Penta D: 13

ST   Penta E: 12,15

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H60

AC   CVCL_A592

SY   H60; H-60

DR   ATCC; CRL-5821

DR   BioSample; SAMN03151862

DR   Cosmic; 1021848

DR   GEO; GSM1682797

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=6108156;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

WW   http://www.atcc.org/support/faqs/d296a/NCIH60%20ATCC%20CRL5821-1064.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-N417 derivative.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5821; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1602 ! NCI-N417

SX   Female

CA   Cancer cell line

//

ID   NCI-H606

AC   CVCL_A575

SY   H606; H-606

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H615

AC   CVCL_A576

SY   H615; H-615

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H618

AC   CVCL_A577

SY   H618; H-618

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H620

AC   CVCL_A578

SY   H620; H-620

DR   Cosmic; 1021868

DR   Cosmic; 1998276

DR   GEO; GSM536332

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H630

AC   CVCL_1572

SY   H630; H-630

DR   CLO; CLO_0008099

DR   EFO; EFO_0002297

DR   ATCC; CRL-5833

DR   BioSample; SAMN03151846

DR   BioSample; SAMN03481113

DR   ChEMBL-Cells; CHEMBL3307966

DR   ChEMBL-Targets; CHEMBL612540

DR   Cosmic; 687535

DR   Cosmic; 908482

DR   Cosmic; 1187327

DR   Cosmic-CLP; 908482

DR   GDSC; 908482

DR   GEO; GSM452725

DR   GEO; GSM452756

DR   GEO; GSM453572

DR   GEO; GSM454623

DR   GEO; GSM454643

DR   GEO; GSM454644

DR   GEO; GSM454645

DR   GEO; GSM1448143

DR   GEO; GSM1670252

DR   IGRhCellID; NCIH630

DR   IZSLER; BS TCL 191

DR   KCLB; 90630

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=27397505;

RX   PubMed=25926053;

WW   http://www.atcc.org/support/faqs/8fa42/NCIH630%20ATCC%20CRL5833-1065.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. The contaminant is not known. Seems to be a mixture of cell lines.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5833; true.

CC   Discontinued: KCLB; 90630; probable.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12,13,14 (ATCC)

ST   D13S317: 11,12,13 (Cosmic-CLP)

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 8,11,12

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,16,17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   NCI-H64

AC   CVCL_1573

SY   H64; H-64

DR   ATCC; CRL-5976

DR   BioSample; SAMN03472629

DR   ChEMBL-Cells; CHEMBL3308273

DR   ChEMBL-Targets; CHEMBL2366319

DR   Cosmic; 688026

DR   Cosmic; 844544

DR   Cosmic; 953985

DR   Cosmic; 1995585

DR   Cosmic-CLP; 688026

DR   GDSC; 688026

DR   GEO; GSM1670253

RX   PubMed=2985257;

RX   PubMed=6108156;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H640

AC   CVCL_A579

SY   H640; H-640

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H647

AC   CVCL_1574

SY   H647; H-647; H647ell; NCIH647

DR   BTO; BTO:0005294

DR   CLO; CLO_0008100

DR   ATCC; CRL-5834

DR   BioSample; SAMN03471319

DR   CCLE; NCIH647_LUNG

DR   ChEMBL-Cells; CHEMBL3308691

DR   ChEMBL-Targets; CHEMBL614999

DR   Cosmic; 722060

DR   Cosmic; 903577

DR   Cosmic; 931370

DR   Cosmic; 980966

DR   Cosmic; 1032438

DR   Cosmic; 1146921

DR   Cosmic; 1891887

DR   Cosmic-CLP; 1240191

DR   GDSC; 1240191

DR   GEO; GSM206497

DR   GEO; GSM434311

DR   GEO; GSM513970

DR   GEO; GSM514351

DR   GEO; GSM784213

DR   GEO; GSM794295

DR   GEO; GSM827587

DR   GEO; GSM844657

DR   GEO; GSM844658

DR   GEO; GSM887438

DR   GEO; GSM888518

DR   GEO; GSM1374758

DR   GEO; GSM1670254

DR   IGRhCellID; H647GEO

DR   KCLB; 90647

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90647; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,11

ST   D16S539: 9

ST   D18S51: 12,15

ST   D21S11: 28,32.2

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 11,13

ST   FGA: 22,24

ST   Penta D: 12,13

ST   Penta E: 7

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H650

AC   CVCL_1575

SY   H650; H-650

DR   BTO; BTO:0004079

DR   CLO; CLO_0008101

DR   EFO; EFO_0002298

DR   ATCC; CRL-5835

DR   BioSample; SAMN03471315

DR   CCLE; NCIH650_LUNG

DR   ChEMBL-Cells; CHEMBL3308461

DR   ChEMBL-Targets; CHEMBL1075543

DR   Cosmic; 722066

DR   Cosmic; 1609512

DR   Cosmic; 1870277

DR   Cosmic; 1995586

DR   Cosmic-CLP; 722066

DR   GDSC; 722066

DR   GEO; GSM206498

DR   GEO; GSM794296

DR   GEO; GSM827481

DR   GEO; GSM887439

DR   GEO; GSM888519

DR   GEO; GSM1670255

DR   IGRhCellID; NCIH650

DR   KCLB; 90650

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 8,11

ST   D18S51: 14,20

ST   D21S11: 31

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 12,14

ST   FGA: 20,22

ST   Penta D: 12

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H650-Luc

AC   CVCL_4Y16

DR   JCRB; NIHS0729

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1575 ! NCI-H650

SX   Male

CA   Cancer cell line

//

ID   NCI-H660

AC   CVCL_1576

SY   H660; H-660; NCIH660; NCI660

DR   BTO; BTO:0001970

DR   CLO; CLO_0008102

DR   ATCC; CRL-5813

DR   BioSample; SAMN03473052

DR   CCLE; NCIH660_PROSTATE

DR   Cosmic; 877360

DR   Cosmic; 1021869

DR   Cosmic; 1043331

DR   Cosmic; 1075272

DR   Cosmic; 1689713

DR   Cosmic-CLP; 1330975

DR   GEO; GSM482672

DR   GEO; GSM648822

DR   GEO; GSM887440

DR   GEO; GSM888520

DR   GEO; GSM1670256

DR   IGRhCellID; NCIH660

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=14518029;

RX   PubMed=22460905;

RX   PubMed=23671654;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   http://capcelllines.ca/details.asp?id=157

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 100 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11

ST   D18S51: 15,16

ST   D21S11: 28,31

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 9,10

ST   FGA: 23,24

ST   Penta D: 9,12

ST   Penta E: 12

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H661

AC   CVCL_1577

SY   H661; H-661; NCIH661

DR   BTO; BTO:0003013

DR   CLO; CLO_0008103

DR   EFO; EFO_0002299

DR   ATCC; HTB-183

DR   BCRC; 60125

DR   BioSample; SAMN03471326

DR   CCLE; NCIH661_LUNG

DR   CCRID; 3111C0001CCC000357

DR   CCRID; 3131C0001000700121

DR   ChEMBL-Cells; CHEMBL3308139

DR   ChEMBL-Targets; CHEMBL1075544

DR   Cosmic; 687829

DR   Cosmic; 877410

DR   Cosmic; 903578

DR   Cosmic; 909909

DR   Cosmic; 923400

DR   Cosmic; 930610

DR   Cosmic; 933579

DR   Cosmic; 961835

DR   Cosmic; 980967

DR   Cosmic; 1006540

DR   Cosmic; 1032439

DR   Cosmic; 1146922

DR   Cosmic; 1152504

DR   Cosmic; 1219063

DR   Cosmic; 1239923

DR   Cosmic; 1995587

DR   Cosmic; 2125186

DR   Cosmic-CLP; 687829

DR   GDSC; 687829

DR   GEO; GSM185870

DR   GEO; GSM206499

DR   GEO; GSM253359

DR   GEO; GSM434273

DR   GEO; GSM784198

DR   GEO; GSM794297

DR   GEO; GSM827517

DR   GEO; GSM887441

DR   GEO; GSM888521

DR   GEO; GSM1670257

DR   IGRhCellID; NCIH661

DR   IZSLER; BS TCL 218

DR   KCB; KCB 200823YJ

RX   PubMed=8806092;

RX   PubMed=9649128;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 61 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 11

ST   D21S11: 31,33.2

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 10

ST   FGA: 20

ST   Penta D: 11,13

ST   Penta E: 12,13

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H676B

AC   CVCL_1578

SY   H676B; H-676B; NCI-H676; H676; H-676

DR   CLO; CLO_0008104

DR   ATCC; HTB-179

DR   BioSample; SAMN03472732

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 10

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H678

AC   CVCL_A580

SY   H678; H-678

DR   Cosmic; 1998277

DR   GEO; GSM536333

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H679

AC   CVCL_A581

SY   H679; H-679

DR   ATCC; CRL-5977

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Discontinued: ATCC; CRL-5977; true.

DI   NCIt; C4038; Lung carcinoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H684

AC   CVCL_9980

SY   H684; H-684

DR   CCLE; NCIH684_LIVER

DR   GEO; GSM1448215

DR   KCLB; 90684

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=25926053;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 10,11

ST   FGA: 23

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H689

AC   CVCL_A582

SY   H689; H-689

DR   KCLB; 90689

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Discontinued: KCLB; 90689; probable.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H69

AC   CVCL_1579

SY   NCI-H-69; NCI H69; H69; H-69; NCIH69; NCI-HUT-69; H69/P; NCI-H69C; H69C; H69c

DR   BTO; BTO:0003022

DR   CLO; CLO_0003609

DR   CLO; CLO_0008105

DR   EFO; EFO_0002300

DR   CLDB; cl1552

DR   ATCC; HTB-119

DR   BioSample; SAMN03473085

DR   CCLE; NCIH69_LUNG

DR   CCRID; 3111C0001CCC000358

DR   ChEMBL-Cells; CHEMBL3307712

DR   ChEMBL-Targets; CHEMBL614805

DR   CLS; 300185/p530_NCI-H69

DR   Cosmic; 688027

DR   Cosmic; 713879

DR   Cosmic; 755459

DR   Cosmic; 801610

DR   Cosmic; 808518

DR   Cosmic; 844545

DR   Cosmic; 844817

DR   Cosmic; 876167

DR   Cosmic; 877351

DR   Cosmic; 918010

DR   Cosmic; 929160

DR   Cosmic; 1006522

DR   Cosmic; 1021849

DR   Cosmic; 1152461

DR   Cosmic; 1175859

DR   Cosmic; 1212189

DR   Cosmic; 1219096

DR   Cosmic; 1239934

DR   Cosmic; 1434964

DR   Cosmic; 1571755

DR   Cosmic; 1609516

DR   Cosmic; 1995588

DR   Cosmic; 1998272

DR   Cosmic; 2125215

DR   Cosmic; 2239080

DR   Cosmic-CLP; 688027

DR   ECACC; 91091802

DR   GDSC; 688027

DR   GEO; GSM169443

DR   GEO; GSM380498

DR   GEO; GSM536334

DR   GEO; GSM784197

DR   GEO; GSM794269

DR   GEO; GSM827305

DR   GEO; GSM845550

DR   GEO; GSM844659

DR   GEO; GSM887442

DR   GEO; GSM888522

DR   GEO; GSM1670258

DR   IGRhCellID; NCIH69

DR   IZSLER; BS TCL 172

DR   KCLB; 30119

RX   PubMed=2574988;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=3034934;

RX   PubMed=6108156;

RX   PubMed=7736387;

RX   PubMed=8626706;

RX   PubMed=8712684;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=9212023;

RX   PubMed=9559344;

RX   PubMed=9744504;

RX   PubMed=9815546;

RX   PubMed=10037197;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=11414198;

RX   PubMed=12569360;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)

ST   Amelogenin: X (CLS)

ST   CSF1PO: 10,12 (ATCC; CLS; ECACC; KCLB)

ST   CSF1PO: 10,13 (Cosmic-CLP; PubMed=25877200)

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 12 (CLS)

ST   D18S51: 12,15 (PubMed=25877200)

ST   D21S11: 30,31.2

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 9

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,11

ST   Penta E: 12

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 17 (Cosmic-CLP; PubMed=25877200)

ST   vWA: 16,17 (ATCC; CLS; ECACC; KCLB)

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/CPR

AC   CVCL_2137

SY   H69/CPR

DR   ECACC; 96042328

RX   PubMed=1327513;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX10

AC   CVCL_2138

SY   H69/LX10

DR   ECACC; 96042331

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX20

AC   CVCL_2139

SY   H69/LX20

DR   CLO; CLO_0008106

DR   ECACC; 96042332

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX4

AC   CVCL_2140

SY   NCI H69-LX4; H69/LX4

DR   ECACC; 96042329

RX   PubMed=3011054;

RX   PubMed=3034934;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69VCR/R

AC   CVCL_3058

DR   ECACC; 96042330

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H711

AC   CVCL_1580

SY   H711; H-711

DR   CLO; CLO_0008107

DR   ATCC; CRL-5836

DR   BioSample; SAMN03471749

DR   Cosmic; 844557

DR   Cosmic; 877211

DR   Cosmic; 877361

DR   Cosmic; 910709

DR   Cosmic; 1032400

DR   Cosmic; 1891906

DR   Cosmic; 2125255

DR   GEO; GSM169446

DR   GEO; GSM827535

RX   PubMed=8806092;

RX   PubMed=8806103;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 9,13

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H716

AC   CVCL_1581

SY   NCI H716; H716; H-716; NCIH716

DR   BTO; BTO:0004747

DR   CLO; CLO_0008108

DR   EFO; EFO_0002301

DR   CLDB; cl3658

DR   ATCC; CCL-251

DR   BCRC; 60517

DR   BioSample; SAMN03473254

DR   CCLE; NCIH716_LARGE_INTESTINE

DR   CCRID; 3111C0001CCC000359

DR   CCRID; 3131C0001001200002

DR   ChEMBL-Cells; CHEMBL3308297

DR   ChEMBL-Targets; CHEMBL2366106

DR   Cosmic; 687536

DR   Cosmic; 908458

DR   Cosmic; 1995589

DR   Cosmic; 2302001

DR   Cosmic-CLP; 908458

DR   GDSC; 908458

DR   GEO; GSM513917

DR   GEO; GSM514304

DR   GEO; GSM887443

DR   GEO; GSM888523

DR   GEO; GSM1346850

DR   GEO; GSM1374759

DR   GEO; GSM1448144

DR   GEO; GSM1670259

DR   IGRhCellID; NCIH716

DR   KCLB; 10251

DR   SKY/M-FISH/CGH; 5013

RX   PubMed=1359704;

RX   PubMed=3479249;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 50 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D18S51: 15,16

ST   D21S11: 32.2

ST   D3S1358: 16,18

ST   D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D5S818: 12 (KCLB)

ST   D7S820: 10,11

ST   D8S1179: 15

ST   FGA: 20,22

ST   Penta D: 9

ST   Penta E: 7,12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H719

AC   CVCL_1582

SY   H719; H-719

DR   CLO; CLO_0008109

DR   ATCC; CRL-5837

DR   BioSample; SAMN03471750

DR   ChEMBL-Cells; CHEMBL3308551

DR   ChEMBL-Targets; CHEMBL2366184

DR   Cosmic; 688028

DR   Cosmic; 844558

DR   Cosmic; 877362

DR   Cosmic; 924242

DR   Cosmic; 980934

DR   Cosmic; 1032401

DR   Cosmic; 1152474

DR   Cosmic; 2125256

DR   GDSC; 924242

DR   KCLB; 90719

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9

ST   D3S1358: 14

ST   D5S818: 13

ST   D7S820: 10

ST   FGA: 20

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 72及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。